Zhongguo shuxue zazhi (Jan 2022)

Anti-Jra developed in Jra(-) pregnant woman, case report with molecular genetic analysis

  • Zhijian LIAO,
  • Shuangshuang JIA,
  • Ling WEI,
  • Zhen WANG,
  • Chunyan MO,
  • Hong Luo,
  • Jizhi WEN,
  • Runqing ZHANG,
  • Guangping LUO,
  • Yanli JI

DOI
https://doi.org/10.13303/j.cjbt.issn.1004-549x.2022.01.029
Journal volume & issue
Vol. 35, no. 1
pp. 102 – 104

Abstract

Read online

Objective To identify the antibody specificity in a pregnant women who had no history of blood transfusion but presented the antibodies against high-frequency antigens. Methods ABO, RhD blood group antigens were identified by saline. Antibody screening and identification were performed by saline and indirect Coomb’s technique. Further antibody identification tests were conducted using papain, trypsin and chymotrypsin-treated cells. Antibody titer in serum was tested. PCR amplification and sequencing analysis of 16 exons of ABCG2 gene were conducted. Results The blood type of the patient were B, RhD positive. The serum reacted with antibody screening/identified cells by indirect antiglobin test(both 2+ ) but not by saline. The agglutination was enhanced after papain treatment (4+ ), but remained unchanged after trypsin and chymotrypsin treatment (2+ ). The IgG titer was 1∶2. The sequencing analysis of ABCG2 gene revealed a homozygous nonsense mutation(c.376C>T, p. Gln126X) in exon 4 of the women. Conclusion In this case, the development of anti-Jra in Jr(a-) mother was stimulated by mother-child serology incompatibility during pregnancy.

Keywords